140 related articles for article (PubMed ID: 28135827)
1. A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network.
Mawocha SC; Fetters MD; Legocki LJ; Guetterman TC; Frederiksen S; Barsan WG; Lewis RJ; Berry DA; Meurer WJ
Clin Trials; 2017 Jun; 14(3):246-254. PubMed ID: 28135827
[TBL] [Abstract][Full Text] [Related]
2. Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project.
Meurer WJ; Legocki L; Mawocha S; Frederiksen SM; Guetterman TC; Barsan W; Lewis R; Berry D; Fetters M
Trials; 2016 Jul; 17():373. PubMed ID: 27473126
[TBL] [Abstract][Full Text] [Related]
3. How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis.
Flight L; Julious S; Brennan A; Todd S; Hind D
Trials; 2020 Mar; 21(1):252. PubMed ID: 32143728
[TBL] [Abstract][Full Text] [Related]
4. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.
Collignon O; Koenig F; Koch A; Hemmings RJ; Pétavy F; Saint-Raymond A; Papaluca-Amati M; Posch M
Trials; 2018 Nov; 19(1):642. PubMed ID: 30454061
[TBL] [Abstract][Full Text] [Related]
5. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
6. 'We all want to succeed, but we've also got to be realistic about what is happening': an ethnographic study of relationships in trial oversight and their impact.
Daykin A; Selman LE; Cramer H; McCann S; Shorter GW; Sydes MR; Gamble C; Macefield R; Lane JA; Shaw A
Trials; 2017 Dec; 18(1):612. PubMed ID: 29273060
[TBL] [Abstract][Full Text] [Related]
7. Key stakeholders' perceptions of the acceptability and usefulness of a tablet-based tool to improve communication and shared decision making in ICUs.
Ernecoff NC; Witteman HO; Chon K; Chen YI; Buddadhumaruk P; Chiarchiaro J; Shotsberger KJ; Shields AM; Myers BA; Hough CL; Carson SS; Lo B; Matthay MA; Anderson WG; Peterson MW; Steingrub JS; Arnold RM; White DB
J Crit Care; 2016 Jun; 33():19-25. PubMed ID: 27037049
[TBL] [Abstract][Full Text] [Related]
8. An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project.
Meurer WJ; Lewis RJ; Tagle D; Fetters MD; Legocki L; Berry S; Connor J; Durkalski V; Elm J; Zhao W; Frederiksen S; Silbergleit R; Palesch Y; Berry DA; Barsan WG
Ann Emerg Med; 2012 Oct; 60(4):451-7. PubMed ID: 22424650
[TBL] [Abstract][Full Text] [Related]
9. Adaptive trials for tuberculosis: early reflections on theory and practice.
Montgomery CM
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1091-8. PubMed ID: 27393545
[TBL] [Abstract][Full Text] [Related]
10. A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis.
Flight L; Arshad F; Barnsley R; Patel K; Julious S; Brennan A; Todd S
Value Health; 2019 Apr; 22(4):391-398. PubMed ID: 30975389
[TBL] [Abstract][Full Text] [Related]
11. Reflections on the Adaptive Designs Accelerating Promising Trials Into Treatments (ADAPT-IT) Process-Findings from a Qualitative Study.
Guetterman TC; Fetters MD; Legocki LJ; Mawocha S; Barsan WG; Lewis RJ; Berry DA; Meurer WJ
Clin Res Regul Aff; 2015 Oct; 32(4):121-130. PubMed ID: 26622163
[TBL] [Abstract][Full Text] [Related]
12. A response adaptive design for ordinal categorical responses.
Biswas A; Bhattacharya R; Das S
J Biopharm Stat; 2018; 28(6):1169-1181. PubMed ID: 29504826
[TBL] [Abstract][Full Text] [Related]
13. Varying viewpoints of Belgian stakeholders on models of interhospital collaboration.
De Regge M; De Pourcq K; Gemmel P; Van de Voorde C; Van den Heede K; Eeckloo K
BMC Health Serv Res; 2018 Dec; 18(1):942. PubMed ID: 30514304
[TBL] [Abstract][Full Text] [Related]
14. Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
Kalkman S; van Thiel GJ; Grobbee DE; Meinecke AK; Zuidgeest MG; van Delden JJ;
Trials; 2016 Aug; 17(1):419. PubMed ID: 27550379
[TBL] [Abstract][Full Text] [Related]
15. Adaptive and platform trials in remote damage control resuscitation.
Tolles J; Lewis RJ
J Trauma Acute Care Surg; 2018 Jun; 84(6S Suppl 1):S28-S34. PubMed ID: 29554037
[TBL] [Abstract][Full Text] [Related]
16. National stakeholders' perceptions of the processes that inform the development of national clinical practice guidelines for primary healthcare in South Africa.
Kredo T; Cooper S; Abrams A; Daniels K; Volmink J; Atkins S
Health Res Policy Syst; 2018 Jul; 16(1):68. PubMed ID: 30064440
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of emergency care research networks: strengths, weaknesses, and challenges.
Papa L; Kuppermann N; Lamond K; Barsan WG; Camargo CA; Ornato JP; Stiell IG; Talan DA
Acad Emerg Med; 2009 Oct; 16(10):995-1004. PubMed ID: 19799579
[TBL] [Abstract][Full Text] [Related]
18. Mixture-based gatekeeping procedures in adaptive clinical trials.
Kordzakhia G; Dmitrienko A; Ishida E
J Biopharm Stat; 2018; 28(1):129-145. PubMed ID: 29283310
[TBL] [Abstract][Full Text] [Related]
19. Preclinical efficacy in investigator's brochures: Stakeholders' views on measures to improve completeness and robustness.
Haslberger M; Schorr SG; Strech D; Haven T
Br J Clin Pharmacol; 2023 Jan; 89(1):340-350. PubMed ID: 35986927
[TBL] [Abstract][Full Text] [Related]
20. Paradigms for adaptive statistical information designs: practical experiences and strategies.
Wang SJ; Hung HM; O'Neill R
Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
